Y-mAbs Therapeutics, Inc.Y-mAbs Therapeutics, Inc.Y-mAbs Therapeutics, Inc.

Y-mAbs Therapeutics, Inc.

Inga transaktioner
Se i superdiagram

YMAB fundamenta

Y-mAbs Therapeutics, Inc. earnings per share and revenue

YMAB earnings per share for the last quarter are -0.15 USD whereas the estimation was -0.14 USD which accounts for -10.29% surprise. Företagets omsättning för samma period uppgår till 19.43 M USD trots den uppskattade siffran 22.21 M USD. Estimated earnings per share for the next quarter are -0.11 USD, and revenue is expected to reach 23.43 M USD. Also watch annual changes over time to get a bigger picture of YMAB earnings per share and revenue dynamics.

Next report date
Report period
EPS estimate
Revenue estimate
Utdelning per andel
‪0.00‬
Rapporterad
Uppskattning
Rapporterad
Uppskattning
Överraskning
Omsättning
‪0.00‬
Rapporterad
Uppskattning
Rapporterad
Uppskattning
Överraskning